The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bovine Vaccines Market Research Report 2025
Synopsis
Vaccines for Bovine
The global Bovine Vaccines market was valued at US$ 1534 million in 2023 and is anticipated to reach US$ 2435.2 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The bovine vaccines market is experiencing steady growth due to the increasing demand for livestock products and the rising prevalence of bovine diseases. Bovine vaccines play a crucial role in preventing and controlling viral, bacterial, and parasitic diseases in cattle. The market is driven by factors such as the growth of the dairy and meat industries, the need to ensure animal health and welfare, and the implementation of stringent disease control measures. Advancements in vaccine technology, including the development of more effective and safer vaccines, are further contributing to market growth. However, challenges such as vaccine storage and transportation requirements, the presence of counterfeit vaccines, and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on disease prevention, biosecurity practices, and sustainable livestock production, the bovine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Bovine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Vaccines.
Report Scope
The Bovine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bovine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Boehringer Ingelheim
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Farm
Government
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccines for Bovine
The global Bovine Vaccines market was valued at US$ 1534 million in 2023 and is anticipated to reach US$ 2435.2 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The bovine vaccines market is experiencing steady growth due to the increasing demand for livestock products and the rising prevalence of bovine diseases. Bovine vaccines play a crucial role in preventing and controlling viral, bacterial, and parasitic diseases in cattle. The market is driven by factors such as the growth of the dairy and meat industries, the need to ensure animal health and welfare, and the implementation of stringent disease control measures. Advancements in vaccine technology, including the development of more effective and safer vaccines, are further contributing to market growth. However, challenges such as vaccine storage and transportation requirements, the presence of counterfeit vaccines, and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on disease prevention, biosecurity practices, and sustainable livestock production, the bovine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Bovine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Vaccines.
Report Scope
The Bovine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bovine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Boehringer Ingelheim
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Farm
Government
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bovine Vaccines Market Overview
1.1 Product Overview and Scope of Bovine Vaccines
1.2 Bovine Vaccines Segment by Type
1.2.1 Global Bovine Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Live Vaccines
1.2.3 Killed Vaccines
1.3 Bovine Vaccines Segment by Application
1.3.1 Global Bovine Vaccines Market Value by Application: (2024-2030)
1.3.2 Farm
1.3.3 Government
1.4 Global Bovine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Bovine Vaccines Revenue 2019-2030
1.4.2 Global Bovine Vaccines Sales 2019-2030
1.4.3 Global Bovine Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bovine Vaccines Market Competition by Manufacturers
2.1 Global Bovine Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bovine Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bovine Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Bovine Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bovine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bovine Vaccines, Product Type & Application
2.7 Bovine Vaccines Market Competitive Situation and Trends
2.7.1 Bovine Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bovine Vaccines Players Market Share by Revenue
2.7.3 Global Bovine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bovine Vaccines Retrospective Market Scenario by Region
3.1 Global Bovine Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bovine Vaccines Global Bovine Vaccines Sales by Region: 2019-2030
3.2.1 Global Bovine Vaccines Sales by Region: 2019-2024
3.2.2 Global Bovine Vaccines Sales by Region: 2025-2030
3.3 Global Bovine Vaccines Global Bovine Vaccines Revenue by Region: 2019-2030
3.3.1 Global Bovine Vaccines Revenue by Region: 2019-2024
3.3.2 Global Bovine Vaccines Revenue by Region: 2025-2030
3.4 North America Bovine Vaccines Market Facts & Figures by Country
3.4.1 North America Bovine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bovine Vaccines Sales by Country (2019-2030)
3.4.3 North America Bovine Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Bovine Vaccines Market Facts & Figures by Country
3.5.1 Europe Bovine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bovine Vaccines Sales by Country (2019-2030)
3.5.3 Europe Bovine Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bovine Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Bovine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bovine Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Bovine Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bovine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Bovine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bovine Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Bovine Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bovine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Bovine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bovine Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bovine Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bovine Vaccines Sales by Type (2019-2030)
4.1.1 Global Bovine Vaccines Sales by Type (2019-2024)
4.1.2 Global Bovine Vaccines Sales by Type (2025-2030)
4.1.3 Global Bovine Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Bovine Vaccines Revenue by Type (2019-2030)
4.2.1 Global Bovine Vaccines Revenue by Type (2019-2024)
4.2.2 Global Bovine Vaccines Revenue by Type (2025-2030)
4.2.3 Global Bovine Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Bovine Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bovine Vaccines Sales by Application (2019-2030)
5.1.1 Global Bovine Vaccines Sales by Application (2019-2024)
5.1.2 Global Bovine Vaccines Sales by Application (2025-2030)
5.1.3 Global Bovine Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Bovine Vaccines Revenue by Application (2019-2030)
5.2.1 Global Bovine Vaccines Revenue by Application (2019-2024)
5.2.2 Global Bovine Vaccines Revenue by Application (2025-2030)
5.2.3 Global Bovine Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Bovine Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jinyu Group
6.1.1 Jinyu Group Corporation Information
6.1.2 Jinyu Group Description and Business Overview
6.1.3 Jinyu Group Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jinyu Group Bovine Vaccines Product Portfolio
6.1.5 Jinyu Group Recent Developments/Updates
6.2 Cavet Bio
6.2.1 Cavet Bio Corporation Information
6.2.2 Cavet Bio Description and Business Overview
6.2.3 Cavet Bio Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cavet Bio Bovine Vaccines Product Portfolio
6.2.5 Cavet Bio Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Corporation Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CAHIC Bovine Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Tecon Group
6.4.1 Tecon Group Corporation Information
6.4.2 Tecon Group Description and Business Overview
6.4.3 Tecon Group Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tecon Group Bovine Vaccines Product Portfolio
6.4.5 Tecon Group Recent Developments/Updates
6.5 Shen Lian
6.5.1 Shen Lian Corporation Information
6.5.2 Shen Lian Description and Business Overview
6.5.3 Shen Lian Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shen Lian Bovine Vaccines Product Portfolio
6.5.5 Shen Lian Recent Developments/Updates
6.6 Biogenesis Bagó
6.6.1 Biogenesis Bagó Corporation Information
6.6.2 Biogenesis Bagó Description and Business Overview
6.6.3 Biogenesis Bagó Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biogenesis Bagó Bovine Vaccines Product Portfolio
6.6.5 Biogenesis Bagó Recent Developments/Updates
6.7 BIGVET Biotech
6.6.1 BIGVET Biotech Corporation Information
6.6.2 BIGVET Biotech Description and Business Overview
6.6.3 BIGVET Biotech Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BIGVET Biotech Bovine Vaccines Product Portfolio
6.7.5 BIGVET Biotech Recent Developments/Updates
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Corporation Information
6.8.2 Indian Immunologicals Description and Business Overview
6.8.3 Indian Immunologicals Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Indian Immunologicals Bovine Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Bovine Vaccines Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 MSD Animal Health
6.10.1 MSD Animal Health Corporation Information
6.10.2 MSD Animal Health Description and Business Overview
6.10.3 MSD Animal Health Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MSD Animal Health Bovine Vaccines Product Portfolio
6.10.5 MSD Animal Health Recent Developments/Updates
6.11 CEVA
6.11.1 CEVA Corporation Information
6.11.2 CEVA Bovine Vaccines Description and Business Overview
6.11.3 CEVA Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CEVA Bovine Vaccines Product Portfolio
6.11.5 CEVA Recent Developments/Updates
6.12 Bayer HealthCare
6.12.1 Bayer HealthCare Corporation Information
6.12.2 Bayer HealthCare Bovine Vaccines Description and Business Overview
6.12.3 Bayer HealthCare Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bayer HealthCare Bovine Vaccines Product Portfolio
6.12.5 Bayer HealthCare Recent Developments/Updates
6.13 VECOL
6.13.1 VECOL Corporation Information
6.13.2 VECOL Bovine Vaccines Description and Business Overview
6.13.3 VECOL Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 VECOL Bovine Vaccines Product Portfolio
6.13.5 VECOL Recent Developments/Updates
6.14 Boehringer Ingelheim
6.14.1 Boehringer Ingelheim Corporation Information
6.14.2 Boehringer Ingelheim Bovine Vaccines Description and Business Overview
6.14.3 Boehringer Ingelheim Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Boehringer Ingelheim Bovine Vaccines Product Portfolio
6.14.5 Boehringer Ingelheim Recent Developments/Updates
6.15 Brilliant Bio Pharma
6.15.1 Brilliant Bio Pharma Corporation Information
6.15.2 Brilliant Bio Pharma Bovine Vaccines Description and Business Overview
6.15.3 Brilliant Bio Pharma Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Brilliant Bio Pharma Bovine Vaccines Product Portfolio
6.15.5 Brilliant Bio Pharma Recent Developments/Updates
6.16 VETAL
6.16.1 VETAL Corporation Information
6.16.2 VETAL Bovine Vaccines Description and Business Overview
6.16.3 VETAL Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 VETAL Bovine Vaccines Product Portfolio
6.16.5 VETAL Recent Developments/Updates
6.17 BVI
6.17.1 BVI Corporation Information
6.17.2 BVI Bovine Vaccines Description and Business Overview
6.17.3 BVI Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 BVI Bovine Vaccines Product Portfolio
6.17.5 BVI Recent Developments/Updates
6.18 LIMOR
6.18.1 LIMOR Corporation Information
6.18.2 LIMOR Bovine Vaccines Description and Business Overview
6.18.3 LIMOR Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 LIMOR Bovine Vaccines Product Portfolio
6.18.5 LIMOR Recent Developments/Updates
6.19 ME VAC
6.19.1 ME VAC Corporation Information
6.19.2 ME VAC Bovine Vaccines Description and Business Overview
6.19.3 ME VAC Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.19.4 ME VAC Bovine Vaccines Product Portfolio
6.19.5 ME VAC Recent Developments/Updates
6.20 Agrovet
6.20.1 Agrovet Corporation Information
6.20.2 Agrovet Bovine Vaccines Description and Business Overview
6.20.3 Agrovet Bovine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Agrovet Bovine Vaccines Product Portfolio
6.20.5 Agrovet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bovine Vaccines Industry Chain Analysis
7.2 Bovine Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bovine Vaccines Production Mode & Process
7.4 Bovine Vaccines Sales and Marketing
7.4.1 Bovine Vaccines Sales Channels
7.4.2 Bovine Vaccines Distributors
7.5 Bovine Vaccines Customers
8 Bovine Vaccines Market Dynamics
8.1 Bovine Vaccines Industry Trends
8.2 Bovine Vaccines Market Drivers
8.3 Bovine Vaccines Market Challenges
8.4 Bovine Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
